Novo CEO pressed by Senate to chop rates of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the corporate would contemplate new talks with insurers concerning the record costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own formularies. Given that some https://busch-light-peach-nutriti52830.thechapblog.com/30061237/the-5-second-trick-for-healthcare-news